Symbol:
Cda
Name:
cytidine deaminase
RGD ID:
1311101
Description:
Enables cytidine deaminase activity. Involved in cellular response to external biotic stimulus; cytidine deamination; and response to cycloheximide. Predicted to be active in cytosol. Human ortholog(s) of this gene implicated in lung non-small cell carcinoma. Orthologous to human CDA (cytidine deaminase); PARTICIPATES IN beta-ureidopropionase deficiency pathway; capecitabine pharmacodynamics pathway; capecitabine pharmacokinetics pathway; INTERACTS WITH 2,3,7,8-tetrachlorodibenzodioxine; 3,3',5,5'-tetrabromobisphenol A; 5-fluorouracil.
Type:
protein-coding
RefSeq Status:
PROVISIONAL
Previously known as:
cytidine deaminase-like; LOC100909857; LOC362638
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
CDA (cytidine deaminase) HGNC
Ensembl, HomoloGene, Inparanoid, OrthoDB, OrthoMCL, Panther, PhylomeDB, Treefam
Mus musculus (house mouse):
Cda (cytidine deaminase) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chinchilla lanigera (long-tailed chinchilla):
Cda (cytidine deaminase) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
CDA (cytidine deaminase) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
CDA (cytidine deaminase) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Cda (cytidine deaminase) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
CDA (cytidine deaminase) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chlorocebus sabaeus (green monkey):
CDA (cytidine deaminase) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Heterocephalus glaber (naked mole-rat):
Cda (cytidine deaminase) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Alliance orthologs 3
Homo sapiens (human):
CDA (cytidine deaminase)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Mus musculus (house mouse):
Cda (cytidine deaminase)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
cdaa
Alliance
DIOPT (Ensembl Compara|OMA|OrthoInspector|PANTHER|PhylomeDB)
Saccharomyces cerevisiae (baker's yeast):
CDD1
Alliance
DIOPT (Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER)
Drosophila melanogaster (fruit fly):
CG8353
Alliance
DIOPT (Hieranoid|InParanoid|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Drosophila melanogaster (fruit fly):
CG8360
Alliance
DIOPT (Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Caenorhabditis elegans (roundworm):
cdd-1
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OrthoFinder|OrthoInspector|PANTHER|SonicParanoid)
Caenorhabditis elegans (roundworm):
cdd-2
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|SonicParanoid)
Danio rerio (zebrafish):
cdab
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoInspector|PANTHER|SonicParanoid)
Drosophila melanogaster (fruit fly):
CG8349
Alliance
DIOPT (Hieranoid|OrthoFinder|PANTHER)
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 5 155,839,929 - 155,866,541 (-) NCBI GRCr8 mRatBN7.2 5 150,556,615 - 150,583,231 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 5 150,556,615 - 150,583,231 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 5 153,252,247 - 153,279,877 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 5 155,026,533 - 155,054,163 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 5 155,008,554 - 155,036,184 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 5 156,703,579 - 156,734,541 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 5 156,703,579 - 156,734,541 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 5 156,757,044 - 156,781,291 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 5 160,452,101 - 160,482,729 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 5 157,117,303 - 157,143,989 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 5 157,127,441 - 157,153,991 (-) NCBI Celera 5 148,950,060 - 148,976,672 (-) NCBI Celera Cytogenetic Map 5 q36 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Cda Rat (1->4)-beta-D-glucan multiple interactions ISO Cda (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CDA mRNA CTD PMID:36331819 Cda Rat 1,1-dichloroethene decreases expression ISO Cda (Mus musculus) 6480464 vinylidene chloride results in decreased expression of CDA mRNA CTD PMID:26682919 Cda Rat 1,2-dichloroethane increases expression ISO Cda (Mus musculus) 6480464 ethylene dichloride results in increased expression of CDA mRNA CTD PMID:28960355 Cda Rat 1,2-dimethylhydrazine decreases expression ISO Cda (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of CDA mRNA CTD PMID:22206623 Cda Rat 17beta-estradiol multiple interactions ISO CDA (Homo sapiens) 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of CDA mRNA and [Progesterone co-treated with Estradiol] affects the expression of CDA mRNA CTD PMID:17404688 and PMID:30165855 Cda Rat 17beta-estradiol increases expression ISO Cda (Mus musculus) 6480464 Estradiol results in increased expression of CDA mRNA CTD PMID:39298647 Cda Rat 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO Cda (Mus musculus) 6480464 2 more ... CTD PMID:30294300 Cda Rat 2,3',4,4',5-Pentachlorobiphenyl increases expression ISO Cda (Mus musculus) 6480464 2 more ... CTD PMID:31388691 Cda Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO CDA (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in increased expression of CDA mRNA CTD PMID:20106945 and PMID:21632981 Cda Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CDA mRNA CTD PMID:33387578 Cda Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Cda (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of CDA mRNA CTD PMID:19933214 Cda Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Cda (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of CDA mRNA CTD PMID:21354282 and PMID:28922406 Cda Rat 2,4-diaminotoluene increases expression ISO Cda (Mus musculus) 6480464 2 and 4-diaminotoluene results in increased expression of CDA mRNA CTD PMID:20713471 Cda Rat 2-hydroxypropanoic acid decreases expression ISO CDA (Homo sapiens) 6480464 Lactic Acid results in decreased expression of CDA mRNA CTD PMID:30851411 Cda Rat 3,3',5,5'-tetrabromobisphenol A decreases expression EXP 6480464 tetrabromobisphenol A results in decreased expression of CDA mRNA CTD PMID:27914987 Cda Rat 3-methylcholanthrene increases expression ISO Cda (Mus musculus) 6480464 Methylcholanthrene results in increased expression of CDA mRNA CTD PMID:20713471 Cda Rat 4-hydroxyphenyl retinamide increases expression ISO Cda (Mus musculus) 6480464 Fenretinide results in increased expression of CDA mRNA CTD PMID:28973697 Cda Rat 4-tert-Octylphenol increases expression ISO Cda (Mus musculus) 6480464 4-tert-octylphenol results in increased expression of CDA mRNA and 4-tert-octylphenol results in increased expression of CDA protein CTD PMID:30487447 Cda Rat 5'-Deoxy-5-fluorocytidine increases metabolic processing ISO Cda (Mus musculus) 6480464 CDA protein results in increased metabolism of 5'-deoxy-5-fluorocytidine CTD PMID:18077151 Cda Rat 5-aza-2'-deoxycytidine increases degradation ISO CDA (Homo sapiens) 6480464 CDA protein results in increased degradation of Decitabine CTD PMID:17616700 Cda Rat 5-fluorocytidine increases metabolic processing ISO CDA (Homo sapiens) 6480464 CDA protein results in increased metabolism of 5-fluorocytidine CTD PMID:21804305 Cda Rat 5-fluorocytidine increases metabolic processing ISO Cda (Mus musculus) 6480464 CDA protein results in increased metabolism of 5-fluorocytidine CTD PMID:21804305 Cda Rat 5-fluorouracil multiple interactions EXP 6480464 [CYP2B1 co-treated with CDA] results in increased susceptibility to [Ifosfamide co-treated with Fluorouracil] and [CYP2B1 co-treated with CDA] results in increased susceptibility to Fluorouracil CTD PMID:10811482 Cda Rat 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of CDA mRNA CTD PMID:24780913 Cda Rat 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of CDA mRNA CTD PMID:22504374 Cda Rat aflatoxin B1 increases expression ISO CDA (Homo sapiens) 6480464 Aflatoxin B1 results in increased expression of CDA mRNA CTD PMID:27153756 Cda Rat aflatoxin B1 decreases methylation ISO CDA (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of CDA intron CTD PMID:30157460 Cda Rat all-trans-retinoic acid increases expression ISO CDA (Homo sapiens) 6480464 Tretinoin results in increased expression of CDA mRNA CTD PMID:33167477 Cda Rat amiodarone increases expression ISO Cda (Mus musculus) 6480464 Amiodarone results in increased expression of CDA mRNA CTD PMID:24535564 Cda Rat arsenite(3-) multiple interactions ISO CDA (Homo sapiens) 6480464 arsenite promotes the reaction [G3BP1 protein binds to CDA mRNA] CTD PMID:32406909 Cda Rat Azoxymethane multiple interactions ISO Cda (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CDA mRNA CTD PMID:29950665 Cda Rat benzo[a]pyrene increases expression ISO Cda (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of CDA mRNA CTD PMID:19770486 Cda Rat benzo[a]pyrene increases expression ISO CDA (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of CDA mRNA CTD PMID:32234424 Cda Rat benzo[a]pyrene affects methylation ISO CDA (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of CDA promoter CTD PMID:27901495 Cda Rat benzo[a]pyrene increases methylation ISO CDA (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of CDA 3' UTR and Benzo(a)pyrene results in increased methylation of CDA exon CTD PMID:27901495 Cda Rat beta-lapachone increases expression ISO CDA (Homo sapiens) 6480464 beta-lapachone results in increased expression of CDA mRNA CTD PMID:38218311 Cda Rat bis(2-ethylhexyl) phthalate increases expression ISO Cda (Mus musculus) 6480464 Diethylhexyl Phthalate results in increased expression of CDA mRNA CTD PMID:28085963 Cda Rat bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of CDA mRNA CTD PMID:25181051 Cda Rat bisphenol A increases expression ISO Cda (Mus musculus) 6480464 bisphenol A results in increased expression of CDA mRNA CTD PMID:32156529 Cda Rat bisphenol A affects expression ISO CDA (Homo sapiens) 6480464 bisphenol A affects the expression of CDA mRNA CTD PMID:30903817 Cda Rat cadmium atom increases expression ISO CDA (Homo sapiens) 6480464 Cadmium results in increased expression of CDA mRNA CTD PMID:21120746 Cda Rat cadmium dichloride increases expression ISO CDA (Homo sapiens) 6480464 Cadmium Chloride results in increased expression of CDA mRNA CTD PMID:38568856 Cda Rat calciol increases expression ISO CDA (Homo sapiens) 6480464 Cholecalciferol results in increased expression of CDA mRNA CTD PMID:18537153 Cda Rat calcitriol increases expression ISO CDA (Homo sapiens) 6480464 Calcitriol results in increased expression of CDA mRNA CTD PMID:16002434 Cda Rat captan increases expression ISO Cda (Mus musculus) 6480464 Captan results in increased expression of CDA mRNA CTD PMID:31558096 Cda Rat carbon nanotube increases expression ISO Cda (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 and PMID:25620056 Cda Rat celastrol increases expression ISO CDA (Homo sapiens) 6480464 celastrol results in increased expression of CDA mRNA CTD PMID:27374097 Cda Rat chlorambucil decreases response to substance ISO CDA (Homo sapiens) 6480464 CDA protein results in decreased susceptibility to Chlorambucil CTD PMID:10830723 Cda Rat chlorpyrifos decreases expression ISO Cda (Mus musculus) 6480464 Chlorpyrifos results in decreased expression of CDA mRNA CTD PMID:37019170 Cda Rat choline multiple interactions ISO Cda (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CDA mRNA CTD PMID:20938992 Cda Rat chromium(6+) affects expression ISO Cda (Mus musculus) 6480464 chromium hexavalent ion affects the expression of CDA mRNA CTD PMID:28472532 Cda Rat cisplatin multiple interactions ISO CDA (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of CDA mRNA CTD PMID:27392435 Cda Rat copper(II) sulfate increases expression ISO CDA (Homo sapiens) 6480464 Copper Sulfate results in increased expression of CDA mRNA CTD PMID:19549813 Cda Rat crizotinib decreases expression ISO CDA (Homo sapiens) 6480464 crizotinib results in decreased expression of CDA protein CTD PMID:22973962 Cda Rat crizotinib multiple interactions ISO CDA (Homo sapiens) 6480464 [Crizotinib results in decreased expression of CDA protein] which results in increased susceptibility to Gemcitabine CTD PMID:22973962 Cda Rat cyclosporin A affects expression ISO CDA (Homo sapiens) 6480464 Cyclosporine affects the expression of CDA mRNA CTD PMID:20106945 Cda Rat cyclosporin A increases expression ISO CDA (Homo sapiens) 6480464 Cyclosporine results in increased expression of CDA mRNA CTD PMID:25562108 Cda Rat dexamethasone increases activity ISO Cda (Mus musculus) 6480464 Dexamethasone results in increased activity of CDA protein CTD PMID:6882797 Cda Rat dextran sulfate multiple interactions ISO Cda (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CDA mRNA CTD PMID:29950665 Cda Rat Dibutyl phosphate affects expression ISO CDA (Homo sapiens) 6480464 di-n-butylphosphoric acid affects the expression of CDA mRNA CTD PMID:37042841 Cda Rat dichloroacetic acid increases expression ISO Cda (Mus musculus) 6480464 Dichloroacetic Acid results in increased expression of CDA mRNA CTD PMID:28962523 Cda Rat dioxygen multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of CDA mRNA CTD PMID:33729688 Cda Rat dorsomorphin multiple interactions ISO CDA (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 Cda Rat entinostat increases expression ISO CDA (Homo sapiens) 6480464 entinostat results in increased expression of CDA mRNA CTD PMID:26272509 Cda Rat entinostat multiple interactions ISO CDA (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDA mRNA CTD PMID:27188386 Cda Rat epoxiconazole affects expression ISO Cda (Mus musculus) 6480464 epoxiconazole affects the expression of CDA mRNA CTD PMID:35436446 Cda Rat fipronil increases expression EXP 6480464 fipronil results in increased expression of CDA mRNA CTD PMID:23962444 Cda Rat folic acid multiple interactions ISO Cda (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CDA mRNA CTD PMID:20938992 Cda Rat folic acid decreases expression ISO Cda (Mus musculus) 6480464 Folic Acid results in decreased expression of CDA mRNA CTD PMID:25629700 Cda Rat folpet increases expression ISO Cda (Mus musculus) 6480464 folpet results in increased expression of CDA mRNA CTD PMID:31558096 Cda Rat formaldehyde increases expression ISO CDA (Homo sapiens) 6480464 Formaldehyde results in increased expression of CDA mRNA CTD PMID:27664576 Cda Rat furan increases expression EXP 6480464 furan results in increased expression of CDA mRNA CTD PMID:25539665 Cda Rat gemcitabine affects response to substance ISO CDA (Homo sapiens) 6480464 CDA protein affects the susceptibility to Gemcitabine CTD PMID:18728667 Cda Rat gemcitabine multiple interactions ISO CDA (Homo sapiens) 6480464 [Crizotinib results in decreased expression of CDA protein] which results in increased susceptibility to Gemcitabine more ... CTD PMID:18728667 and PMID:22973962 Cda Rat genistein decreases expression ISO Cda (Mus musculus) 6480464 Genistein results in decreased expression of CDA mRNA CTD PMID:32186404 Cda Rat gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of CDA mRNA CTD PMID:33387578 Cda Rat gold atom multiple interactions ISO Cda (Mus musculus) 6480464 [Gold co-treated with Polyethylene Glycols] results in decreased expression of CDA mRNA CTD PMID:19695318 Cda Rat gold(0) multiple interactions ISO Cda (Mus musculus) 6480464 [Gold co-treated with Polyethylene Glycols] results in decreased expression of CDA mRNA CTD PMID:19695318 Cda Rat hydrogen peroxide affects expression ISO CDA (Homo sapiens) 6480464 Hydrogen Peroxide affects the expression of CDA mRNA CTD PMID:20044591 Cda Rat ifosfamide multiple interactions EXP 6480464 [CYP2B1 co-treated with CDA] results in increased susceptibility to [Ifosfamide co-treated with Fluorouracil] and [CYP2B1 co-treated with CDA] results in increased susceptibility to Ifosfamide CTD PMID:10811482 Cda Rat inulin multiple interactions ISO Cda (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of CDA mRNA CTD PMID:36331819 Cda Rat isotretinoin decreases expression ISO CDA (Homo sapiens) 6480464 Isotretinoin results in decreased expression of CDA mRNA CTD PMID:20436886 Cda Rat L-methionine multiple interactions ISO Cda (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CDA mRNA CTD PMID:20938992 Cda Rat melphalan decreases response to substance ISO CDA (Homo sapiens) 6480464 CDA protein results in decreased susceptibility to Melphalan CTD PMID:10830723 Cda Rat methimazole increases expression EXP 6480464 Methimazole results in increased expression of CDA mRNA CTD PMID:22504374 Cda Rat mitomycin C multiple interactions ISO CDA (Homo sapiens) 6480464 CDA protein affects the susceptibility to [Gemcitabine co-treated with Mitomycin] CTD PMID:18728667 Cda Rat oxaliplatin multiple interactions ISO CDA (Homo sapiens) 6480464 CDA protein affects the susceptibility to [Gemcitabine co-treated with Oxaliplatin] CTD PMID:18728667 Cda Rat p-tert-Amylphenol increases expression ISO Cda (Mus musculus) 6480464 4-tert-octylphenol results in increased expression of CDA mRNA and 4-tert-octylphenol results in increased expression of CDA protein CTD PMID:30487447 Cda Rat paclitaxel affects response to substance ISO CDA (Homo sapiens) 6480464 CDA protein affects the susceptibility to Paclitaxel CTD PMID:18728667 Cda Rat paracetamol affects expression ISO Cda (Mus musculus) 6480464 Acetaminophen affects the expression of CDA mRNA CTD PMID:17562736 Cda Rat paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of CDA mRNA CTD PMID:33387578 Cda Rat perfluorooctane-1-sulfonic acid multiple interactions ISO Cda (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CDA mRNA more ... CTD PMID:36331819 Cda Rat phenobarbital decreases expression ISO Cda (Mus musculus) 6480464 Phenobarbital results in decreased expression of CDA mRNA CTD PMID:19270015 Cda Rat phenylmercury acetate decreases expression ISO CDA (Homo sapiens) 6480464 Phenylmercuric Acetate results in decreased expression of CDA mRNA CTD PMID:26272509 Cda Rat phenylmercury acetate multiple interactions ISO CDA (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDA mRNA CTD PMID:27188386 Cda Rat pirinixic acid multiple interactions ISO Cda (Mus musculus) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CDA mRNA CTD PMID:19710929 Cda Rat pirinixic acid increases expression ISO Cda (Mus musculus) 6480464 pirinixic acid results in increased expression of CDA mRNA CTD PMID:17426115 more ... Cda Rat progesterone multiple interactions ISO CDA (Homo sapiens) 6480464 [Progesterone co-treated with Estradiol] affects the expression of CDA mRNA CTD PMID:17404688 Cda Rat protein kinase inhibitor multiple interactions ISO CDA (Homo sapiens) 6480464 Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of CDA mRNA] CTD PMID:28003376 Cda Rat quercetin increases expression ISO CDA (Homo sapiens) 6480464 Quercetin results in increased expression of CDA mRNA CTD PMID:21632981 Cda Rat rac-lactic acid decreases expression ISO CDA (Homo sapiens) 6480464 Lactic Acid results in decreased expression of CDA mRNA CTD PMID:30851411 Cda Rat SB 431542 multiple interactions ISO CDA (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 Cda Rat silicon dioxide increases expression ISO CDA (Homo sapiens) 6480464 Silicon Dioxide analog results in increased expression of CDA mRNA and Silicon Dioxide results in increased expression of CDA mRNA CTD PMID:25351596 and PMID:25895662 Cda Rat silicon dioxide decreases expression ISO Cda (Mus musculus) 6480464 Silicon Dioxide results in decreased expression of CDA mRNA CTD PMID:23221170 Cda Rat silver atom increases expression ISO Cda (Mus musculus) 6480464 Silver results in increased expression of CDA mRNA CTD PMID:27131904 Cda Rat silver(0) increases expression ISO Cda (Mus musculus) 6480464 Silver results in increased expression of CDA mRNA CTD PMID:27131904 Cda Rat sodium arsenite increases expression ISO CDA (Homo sapiens) 6480464 sodium arsenite results in increased expression of CDA mRNA CTD PMID:22714537 Cda Rat succimer multiple interactions ISO Cda (Mus musculus) 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CDA mRNA and [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CDA mRNA CTD PMID:21641980 and PMID:26378955 Cda Rat sulforaphane increases expression ISO CDA (Homo sapiens) 6480464 sulforaphane results in increased expression of CDA mRNA CTD PMID:26833863 Cda Rat sulforaphane decreases expression ISO CDA (Homo sapiens) 6480464 sulforaphane results in decreased expression of CDA mRNA CTD PMID:31838189 Cda Rat tamoxifen decreases expression ISO Cda (Mus musculus) 6480464 Tamoxifen results in decreased expression of CDA mRNA CTD PMID:25123088 Cda Rat tamoxifen affects expression ISO Cda (Mus musculus) 6480464 Tamoxifen affects the expression of CDA mRNA CTD PMID:20937368 Cda Rat Tegafur affects response to substance ISO CDA (Homo sapiens) 6480464 CDA gene polymorphism affects the susceptibility to Tegafur CTD PMID:18537153 Cda Rat testosterone decreases expression ISO CDA (Homo sapiens) 6480464 Testosterone results in decreased expression of CDA mRNA CTD PMID:33359661 Cda Rat tetrachloromethane increases expression ISO Cda (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of CDA mRNA CTD PMID:31919559 Cda Rat titanium dioxide increases expression ISO Cda (Mus musculus) 6480464 titanium dioxide results in increased expression of CDA mRNA CTD PMID:27760801 Cda Rat titanium dioxide multiple interactions ISO Cda (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CDA mRNA CTD PMID:29950665 Cda Rat trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of CDA mRNA CTD PMID:33387578 Cda Rat triphenyl phosphate affects expression ISO CDA (Homo sapiens) 6480464 triphenyl phosphate affects the expression of CDA mRNA CTD PMID:37042841 Cda Rat valproic acid increases expression ISO Cda (Mus musculus) 6480464 Valproic Acid results in increased expression of CDA mRNA CTD PMID:24535564 Cda Rat valproic acid increases expression ISO CDA (Homo sapiens) 6480464 Valproic Acid results in increased expression of CDA mRNA CTD PMID:23179753 more ... Cda Rat valproic acid multiple interactions ISO CDA (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDA mRNA CTD PMID:27188386
Imported Annotations - SMPDB
Imported Annotations - KEGG (archival)
(1->4)-beta-D-glucan (ISO) 1,1-dichloroethene (ISO) 1,2-dichloroethane (ISO) 1,2-dimethylhydrazine (ISO) 17beta-estradiol (ISO) 2,2',4,4'-Tetrabromodiphenyl ether (ISO) 2,3',4,4',5-Pentachlorobiphenyl (ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2,4-diaminotoluene (ISO) 2-hydroxypropanoic acid (ISO) 3,3',5,5'-tetrabromobisphenol A (EXP) 3-methylcholanthrene (ISO) 4-hydroxyphenyl retinamide (ISO) 4-tert-Octylphenol (ISO) 5'-Deoxy-5-fluorocytidine (ISO) 5-aza-2'-deoxycytidine (ISO) 5-fluorocytidine (ISO) 5-fluorouracil (EXP) 6-propyl-2-thiouracil (EXP) aflatoxin B1 (ISO) all-trans-retinoic acid (ISO) amiodarone (ISO) arsenite(3-) (ISO) Azoxymethane (ISO) benzo[a]pyrene (ISO) beta-lapachone (ISO) bis(2-ethylhexyl) phthalate (ISO) bisphenol A (EXP,ISO) cadmium atom (ISO) cadmium dichloride (ISO) calciol (ISO) calcitriol (ISO) captan (ISO) carbon nanotube (ISO) celastrol (ISO) chlorambucil (ISO) chlorpyrifos (ISO) choline (ISO) chromium(6+) (ISO) cisplatin (ISO) copper(II) sulfate (ISO) crizotinib (ISO) cyclosporin A (ISO) dexamethasone (ISO) dextran sulfate (ISO) Dibutyl phosphate (ISO) dichloroacetic acid (ISO) dioxygen (EXP) dorsomorphin (ISO) entinostat (ISO) epoxiconazole (ISO) fipronil (EXP) folic acid (ISO) folpet (ISO) formaldehyde (ISO) furan (EXP) gemcitabine (ISO) genistein (ISO) gentamycin (EXP) gold atom (ISO) gold(0) (ISO) hydrogen peroxide (ISO) ifosfamide (EXP) inulin (ISO) isotretinoin (ISO) L-methionine (ISO) melphalan (ISO) methimazole (EXP) mitomycin C (ISO) oxaliplatin (ISO) p-tert-Amylphenol (ISO) paclitaxel (ISO) paracetamol (EXP,ISO) perfluorooctane-1-sulfonic acid (ISO) phenobarbital (ISO) phenylmercury acetate (ISO) pirinixic acid (ISO) progesterone (ISO) protein kinase inhibitor (ISO) quercetin (ISO) rac-lactic acid (ISO) SB 431542 (ISO) silicon dioxide (ISO) silver atom (ISO) silver(0) (ISO) sodium arsenite (ISO) succimer (ISO) sulforaphane (ISO) tamoxifen (ISO) Tegafur (ISO) testosterone (ISO) tetrachloromethane (ISO) titanium dioxide (ISO) trichloroethene (EXP) triphenyl phosphate (ISO) valproic acid (ISO)
1.
Adenosine deaminase, 5'-nucleotidase, guanase and cytidine deaminase activities in gastric tissues from patients with gastric cancer.
Durak I, etal., Cancer Lett. 1994 Sep 15;84(2):199-202. doi: 10.1016/0304-3835(94)90376-x.
2.
Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.
Gaudet P, etal., Brief Bioinform. 2011 Sep;12(5):449-62. doi: 10.1093/bib/bbr042. Epub 2011 Aug 27.
3.
Rat ISS GO annotations from GOA human gene data--August 2006
GOA data from the GO Consortium
4.
Rat ISS GO annotations from MGI mouse gene data--August 2006
MGD data from the GO Consortium
5.
Development of multidrug resistance due to multiple factors including P-glycoprotein overexpression under K-selection after MYC and HRAS oncogene activation.
Nakamura Y, etal., Int J Cancer. 2006 May 15;118(10):2448-54.
6.
Identification of new SNPs associated with severe toxicity to capecitabine.
Pellicer M, etal., Pharmacol Res. 2017 Jun;120:133-137. doi: 10.1016/j.phrs.2017.03.021. Epub 2017 Mar 27.
7.
KEGG Annotation Import Pipeline
Pipeline to import KEGG annotations from KEGG into RGD
8.
SMPDB Annotation Import Pipeline
Pipeline to import SMPDB annotations from SMPDB into RGD
9.
ClinVar Automated Import and Annotation Pipeline
RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
10.
Data Import for Chemical-Gene Interactions
RGD automated import pipeline for gene-chemical interactions
11.
Pyrimidine nucleotide synthesis in rat liver after the administration of cycloheximide.
Seifert J and Vacha J, Toxicology. 1978 May;10(1):29-38.
12.
Pharmacokinetics of gemcitabine in Japanese cancer patients: the impact of a cytidine deaminase polymorphism.
Sugiyama E, etal., J Clin Oncol. 2007 Jan 1;25(1):32-42.
13.
Correlation of CDA, ERCC1, and XPD polymorphisms with response and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients.
Tibaldi C, etal., Clin Cancer Res. 2008 Mar 15;14(6):1797-803.
Cda Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 5 155,839,929 - 155,866,541 (-) NCBI GRCr8 mRatBN7.2 5 150,556,615 - 150,583,231 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 5 150,556,615 - 150,583,231 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 5 153,252,247 - 153,279,877 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 5 155,026,533 - 155,054,163 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 5 155,008,554 - 155,036,184 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 5 156,703,579 - 156,734,541 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 5 156,703,579 - 156,734,541 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 5 156,757,044 - 156,781,291 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 5 160,452,101 - 160,482,729 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 5 157,117,303 - 157,143,989 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 5 157,127,441 - 157,153,991 (-) NCBI Celera 5 148,950,060 - 148,976,672 (-) NCBI Celera Cytogenetic Map 5 q36 NCBI
CDA Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 1 20,589,097 - 20,618,903 (+) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 1 20,589,086 - 20,618,903 (+) Ensembl GRCh38 hg38 GRCh38 GRCh37 1 20,915,590 - 20,945,396 (+) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 1 20,788,031 - 20,817,988 (+) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 1 20,660,836 - 20,690,702 NCBI Celera 1 19,239,772 - 19,269,752 (+) NCBI Celera Cytogenetic Map 1 p36.12 NCBI HuRef 1 19,161,467 - 19,190,528 (+) NCBI HuRef CHM1_1 1 21,025,824 - 21,055,781 (+) NCBI CHM1_1 T2T-CHM13v2.0 1 20,414,048 - 20,443,922 (+) NCBI T2T-CHM13v2.0
Cda Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 4 138,065,839 - 138,095,623 (-) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 4 138,065,735 - 138,095,303 (-) Ensembl GRCm39 Ensembl GRCm38 4 138,338,528 - 138,368,311 (-) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 4 138,338,424 - 138,367,992 (-) Ensembl GRCm38 mm10 GRCm38 MGSCv37 4 137,894,443 - 137,923,870 (-) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 4 137,610,604 - 137,640,031 (-) NCBI MGSCv36 mm8 Celera 4 140,122,623 - 140,152,350 (-) NCBI Celera Cytogenetic Map 4 D3 NCBI cM Map 4 70.17 NCBI
Cda Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955452 1,132,049 - 1,156,565 (+) Ensembl ChiLan1.0 ChiLan1.0 NW_004955452 1,131,968 - 1,156,777 (+) NCBI ChiLan1.0 ChiLan1.0
CDA Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 1 206,506,028 - 206,535,363 (-) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 1 205,618,335 - 205,647,685 (-) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 1 19,538,696 - 19,568,008 (+) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 1 20,583,441 - 20,612,711 (+) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 1 20,583,441 - 20,612,711 (+) Ensembl panpan1.1 panPan2
CDA Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 2 78,305,328 - 78,327,229 (-) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 2 78,304,726 - 78,327,247 (-) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 2 74,819,639 - 74,841,500 (-) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 2 78,872,416 - 78,894,283 (-) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 2 78,870,359 - 78,894,541 (-) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 2 75,690,869 - 75,712,919 (-) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 2 76,702,707 - 76,724,560 (-) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 2 77,706,391 - 77,728,271 (-) NCBI UU_Cfam_GSD_1.0
Cda Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024405058 40,718,495 - 40,739,795 (+) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936474 6,543,220 - 6,566,308 (+) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936474 6,543,295 - 6,564,575 (+) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
CDA Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 6 78,824,270 - 78,849,547 (+) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 6 78,824,248 - 78,849,154 (+) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 6 73,017,555 - 73,042,459 (+) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
CDA Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 20 111,931,365 - 111,960,172 (-) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 20 111,931,364 - 111,960,036 (-) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666033 4,270,608 - 4,299,725 (+) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Cda
.
Predicted Target Of
Count of predictions: 140 Count of miRNA genes: 88 Interacting mature miRNAs: 106 Transcripts: ENSRNOT00000021036, ENSRNOT00000075128 Prediction methods: Microtar, Miranda, Rnahybrid, Targetscan Result types: miRGate_prediction
10053720 Scort26 Serum corticosterone level QTL 26 2.06 0.0147 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 5 124965598 166875058 Rat 8552960 Pigfal15 Plasma insulin-like growth factor 1 level QTL 15 blood insulin-like growth factor amount (VT:0010479) plasma insulin-like growth factor 1 level (CMO:0001299) 5 111416838 156416838 Rat 2302369 Scl60 Serum cholesterol level QTL 60 3.13 blood cholesterol amount (VT:0000180) serum total cholesterol level (CMO:0000363) 5 143608201 161165651 Rat 631562 Apr2 Acute phase response QTL 2 3.7 blood murinoglobulin 1 amount (VT:0010597) plasma murinoglobulin 1 level (CMO:0001931) 5 135927956 166875058 Rat 61444 Strs2 Sensitivity to stroke QTL 2 4.7 cerebrum integrity trait (VT:0010549) post-insult time to onset of cerebrovascular lesion (CMO:0002343) 5 135929696 166875058 Rat 1300119 Bp180 Blood pressure QTL 180 3.82 arterial blood pressure trait (VT:2000000) blood pressure time series experimental set point of the baroreceptor response (CMO:0002593) 5 144358090 157869054 Rat 70156 Niddm30 Non-insulin dependent diabetes mellitus QTL 30 3.98 blood glucose amount (VT:0000188) blood glucose level area under curve (AUC) (CMO:0000350) 5 129132447 151006154 Rat 8552908 Pigfal4 Plasma insulin-like growth factor 1 level QTL 4 6.6 blood insulin-like growth factor amount (VT:0010479) plasma insulin-like growth factor 1 level (CMO:0001299) 5 128506074 166875058 Rat 61393 Bp7 Blood pressure QTL 7 4.5 0.0001 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 5 60293434 161481680 Rat 7794791 Mcs33 Mammary carcinoma susceptibility QTL 33 1.93 mammary gland integrity trait (VT:0010552) mammary tumor incidence/prevalence measurement (CMO:0000946) 5 131345754 166875058 Rat 7207486 Bss109 Bone structure and strength QTL 109 femur strength trait (VT:0010010) femur total energy absorbed before break (CMO:0001677) 5 106906205 151906205 Rat 7207481 Bss106 Bone structure and strength QTL 106 7.9 femur strength trait (VT:0010010) femur ultimate force (CMO:0001675) 5 106906205 151906205 Rat 1302790 Scl20 Serum cholesterol level QTL 20 6.4 0.0001 blood cholesterol amount (VT:0000180) plasma total cholesterol level (CMO:0000585) 5 82394392 166664054 Rat 1598861 Cm64 Cardiac mass QTL 64 2.9 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 5 127798274 166875058 Rat 1578766 Tcas11 Tongue tumor susceptibility QTL 11 4.12 tongue integrity trait (VT:0010553) number of squamous cell tumors of the tongue with diameter greater than 3 mm (CMO:0001950) 5 46711509 161317411 Rat 631263 Cm24 Cardiac mass QTL 24 3.5 heart mass (VT:0007028) heart left ventricle weight to body weight ratio (CMO:0000530) 5 143799107 158428037 Rat 631505 Bp103 Blood pressure QTL 103 3.2 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 5 132717196 165560427 Rat 1549838 Bss4 Bone structure and strength QTL 4 9.2 femur strength trait (VT:0010010) femur midshaft polar moment of inertia (CMO:0001669) 5 106906205 151906205 Rat 1641920 Colcs1 Colorectal carcinoma susceptibility QTL 1 2.99 0.0055 intestine integrity trait (VT:0010554) benign colorectal tumor surface area measurement (CMO:0001799) 5 121846814 166846814 Rat 8694169 Bw148 Body weight QTL 148 5 0.001 body mass (VT:0001259) body weight gain (CMO:0000420) 5 128506074 166875058 Rat 1331721 Bp210 Blood pressure QTL 210 3.413 arterial blood pressure trait (VT:2000000) blood pressure time series experimental set point of the baroreceptor response (CMO:0002593) 5 143069996 166846814 Rat 8657050 Bw146 Body weight QTL 146 19.84 0.001 body mass (VT:0001259) body weight gain (CMO:0000420) 5 108938288 153938288 Rat 1576314 Eutr1 Estrogen induced uterine response QTL 1 uterus integrity trait (VT:0010575) pyometritis severity score (CMO:0002009) 5 2138965 166875058 Rat 2317056 Wbc3 White blood cell count QTL 3 2.51 0.01 leukocyte quantity (VT:0000217) white blood cell count (CMO:0000027) 5 105999803 150999803 Rat 634349 Bp139 Blood pressure QTL 139 0.001 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 5 128924607 166875058 Rat 724525 Bp147 Blood pressure QTL 147 4.3 0.0001 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 5 126424772 166875058 Rat 1598847 Cm62 Cardiac mass QTL 62 3.4 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 5 108845856 153845856 Rat 2293642 Bss37 Bone structure and strength QTL 37 4.64 0.0001 femur strength trait (VT:0010010) femur ultimate force (CMO:0001675) 5 120740824 151018848 Rat 738018 Anxrr4 Anxiety related response QTL 4 5.1 exploratory behavior trait (VT:0010471) percentage of entries into a discrete space in an experimental apparatus (CMO:0000961) 5 130130159 166875058 Rat 2313096 Bmd78 Bone mineral density QTL 78 3.1 0.0001 tibia mineral mass (VT:1000283) total volumetric bone mineral density (CMO:0001728) 5 144377876 161317411 Rat 7207488 Bss110 Bone structure and strength QTL 1 8.4 femur strength trait (VT:0010010) femur stiffness (CMO:0001674) 5 106906205 151906205 Rat 8694441 Bw169 Body weight QTL 169 17.61 0.001 retroperitoneal fat pad mass (VT:0010430) retroperitoneal fat pad weight to body weight ratio (CMO:0000635) 5 111416838 156416838 Rat 7207491 Bss112 Bone structure and strength QTL 112 7 femur morphology trait (VT:0000559) femur midshaft cortical cross-sectional area (CMO:0001663) 5 106906205 151906205 Rat 8694389 Bw160 Body weight QTL 160 6.17 0.001 body lean mass (VT:0010483) lean tissue morphological measurement (CMO:0002184) 5 111416838 156416838 Rat 1354598 Srn6 Serum renin concentration QTL 6 3.8 blood renin amount (VT:0003349) plasma renin activity level (CMO:0000116) 5 69540295 151018848 Rat 8694198 Abfw3 Abdominal fat weight QTL 3 16.13 0.001 visceral adipose mass (VT:0010063) abdominal fat pad weight to body weight ratio (CMO:0000095) 5 111416838 156416838 Rat 1298089 Scl14 Serum cholesterol level QTL 14 5.8 0.0004 blood cholesterol amount (VT:0000180) plasma total cholesterol level (CMO:0000585) 5 108845856 153845856 Rat 1598819 Bp292 Blood pressure QTL 292 4.3 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 5 127798274 166875058 Rat
RH141036
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 5 150,556,910 - 150,557,109 (+) MAPPER mRatBN7.2 Rnor_6.0 5 156,756,874 - 156,757,072 NCBI Rnor6.0 Rnor_6.0 5 156,703,875 - 156,704,073 NCBI Rnor6.0 Rnor_5.0 5 160,505,087 - 160,505,285 UniSTS Rnor5.0 Rnor_5.0 5 160,452,397 - 160,452,595 UniSTS Rnor5.0 RGSC_v3.4 5 157,117,599 - 157,117,797 UniSTS RGSC3.4 Celera 5 148,950,356 - 148,950,554 UniSTS RH 3.4 Map 5 1032.4 UniSTS Cytogenetic Map 5 q36 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
3
10
43
67
20
26
17
3
17
101
49
66
24
39
9
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000021036 ⟹ ENSRNOP00000021036
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 5 150,556,615 - 150,583,231 (-) Ensembl Rnor_6.0 Ensembl 5 156,703,579 - 156,734,541 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000075128 ⟹ ENSRNOP00000065378
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source Rnor_6.0 Ensembl 5 156,757,044 - 156,781,291 (-) Ensembl
RefSeq Acc Id:
NM_001108688 ⟹ NP_001102158
RefSeq Status:
PROVISIONAL
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 5 155,839,929 - 155,866,541 (-) NCBI mRatBN7.2 5 150,556,615 - 150,583,231 (-) NCBI Rnor_6.0 5 156,703,579 - 156,734,541 (-) NCBI Rnor_5.0 5 160,452,101 - 160,482,729 (-) NCBI RGSC_v3.4 5 157,117,303 - 157,143,989 (-) RGD Celera 5 148,950,060 - 148,976,672 (-) RGD
Sequence:
TAGTCTGCAGCTGCTAGCTCACTCTCCTCGGACCGACATGGCCCAGGAACGCCCCTCCTGTGCCGTGGAGCCTGAGCACGTCCAGCGGCTGCTGCTGTCCTCTCGTGAAGCCAAGAAGTCAGCCTACT
hide sequence
RefSeq Acc Id:
XM_039110422 ⟹ XP_038966350
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 5 155,840,029 - 155,859,562 (-) NCBI mRatBN7.2 5 150,556,715 - 150,576,217 (-) NCBI
RefSeq Acc Id:
NP_001102158 ⟸ NM_001108688
- UniProtKB:
D4AC20 (UniProtKB/TrEMBL), A6ITH4 (UniProtKB/TrEMBL)
- Sequence:
MAQERPSCAVEPEHVQRLLLSSREAKKSAYCPYSRFPVGAALLTGDGRIFSGCNVENACYPLGVCAERTAIQKAISEGYKDFRAIAIASDLQEEFISPCGACRQVMREFGTNWAVYMTKPDGTFVVRT
hide sequence
Ensembl Acc Id:
ENSRNOP00000021036 ⟸ ENSRNOT00000021036
RefSeq Acc Id:
XP_038966350 ⟸ XM_039110422
- Peptide Label:
isoform X1
Ensembl Acc Id:
ENSRNOP00000065378 ⟸ ENSRNOT00000075128
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2021-03-09
Cda
cytidine deaminase
LOC100909857
cytidine deaminase-like
Data merged from RGD:6501229
737654 PROVISIONAL
2012-07-05
LOC100909857
cytidine deaminase-like
Symbol and Name status set to provisional
70820 PROVISIONAL
2008-04-30
Cda
cytidine deaminase
Cda_predicted
cytidine deaminase (predicted)
'predicted' is removed
2292626 APPROVED
2005-01-12
Cda_predicted
cytidine deaminase (predicted)
Symbol and Name status set to approved
70820 APPROVED
